Literature DB >> 24054177

Dietary sodium restriction: take it with a grain of salt.

James J DiNicolantonio1, Asfandyar K Niazi, Rizwana Sadaf, James H O' Keefe, Sean C Lucan, Carl J Lavie.   

Abstract

The American Heart Association recently strongly recommended a dietary sodium intake of <1500 mg/d for all Americans to achieve "Ideal Cardiovascular Health" by 2020. However, low sodium diets have not been shown to reduce cardiovascular events in normotensive individuals or in individuals with pre-hypertension or hypertension. Moreover, there is evidence that a low sodium diet may lead to a worse cardiovascular prognosis in patients with cardiometabolic risk and established cardiovascular disease. Low sodium diets may adversely affect insulin resistance, serum lipids, and neurohormonal pathways, leading to increases in the incidence of new cardiometabolic disease, the severity of existing cardiometabolic disease, and greater cardiovascular and all-cause mortality. Although a high sodium intake also may be deleterious, there is good reason to believe that sodium intake is regulated within such a tight physiologic range that there is little risk to leaving sodium intake to inherent biology as opposed to likely futile attempts at conscious control.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiology; Cardiovascular health; Public health; Salt; Sodium

Mesh:

Substances:

Year:  2013        PMID: 24054177     DOI: 10.1016/j.amjmed.2013.05.020

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Dietary sodium restriction: still searching for the grains of truth.

Authors:  Scott L Hummel; Alan B Weder
Journal:  Am J Med       Date:  2014-06       Impact factor: 4.965

2.  Problems with the 2015 Dietary Guidelines for Americans: A Response to a Rebuttal.

Authors:  James J DiNicolantonio; Zoe Harcombe; James H O'Keefe
Journal:  Mo Med       Date:  2016 Jul-Aug

3.  Recent publications by ochsner authors: october 2013 - march 2014.

Authors: 
Journal:  Ochsner J       Date:  2014

Review 4.  Problems with the 2015 Dietary Guidelines for Americans: An Alternative.

Authors:  James J DiNicolantonio; Zoë Harcombe; James H O'Keefe
Journal:  Mo Med       Date:  2016 Mar-Apr

Review 5.  The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

Authors:  Ines Armando; Prasad Konkalmatt; Robin A Felder; Pedro A Jose
Journal:  Transl Res       Date:  2014-07-25       Impact factor: 7.012

6.  RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

Authors:  Suman Srinivasa; Kathleen V Fitch; Kimberly Wong; Martin Torriani; Caitlin Mayhew; Takara Stanley; Janet Lo; Gail K Adler; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2015-06-18       Impact factor: 5.958

7.  Expression of mineralocorticoid and glucocorticoid receptors in preautonomic neurons of the rat paraventricular nucleus.

Authors:  Jian Chen; Celso E Gomez-Sanchez; Alan Penman; Paul J May; Elise Gomez-Sanchez
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-31       Impact factor: 3.619

Review 8.  The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease.

Authors:  James J DiNicolantonio; Sean C Lucan
Journal:  Open Heart       Date:  2014-11-03

9.  Factors predicting meat and meat products consumption among middle-aged and elderly people: evidence from a consumer survey in Switzerland.

Authors:  Alexandra Schmid; Doreen Gille; Patrizia Piccinali; Ueli Bütikofer; Magali Chollet; Themistoklis Altintzoglou; Pirjo Honkanen; Barbara Walther; Helena Stoffers
Journal:  Food Nutr Res       Date:  2017-04-24       Impact factor: 3.894

10.  High-Salt Intake Ameliorates Hyperglycemia and Insulin Resistance in WBN/Kob-Leprfa/fa Rats: A New Model of Type 2 Diabetes Mellitus.

Authors:  Yoshiichi Takagi; Taichi Sugimoto; Masaya Kobayashi; Mitsuyuki Shirai; Fumitoshi Asai
Journal:  J Diabetes Res       Date:  2018-03-20       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.